We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App

New Hydrogel Features Enhanced Capabilities for Treating Aneurysms and Halting Progression

By HospiMedica International staff writers
Posted on 27 Mar 2024
Print article
Image: Researchers have developed an advanced shear-thinning hydrogel for aneurysm repair (Photo courtesy of TIBI)
Image: Researchers have developed an advanced shear-thinning hydrogel for aneurysm repair (Photo courtesy of TIBI)

Aneurysms can develop in blood vessels in different body areas, often as a result of atherosclerosis, infections, inflammatory diseases, and other risk factors. These conditions lead to chronic inflammation, causing the cells lining the inside of blood vessels to produce an overabundance of enzymes known as matrix metalloproteinases (MMPs). These MMPs break down the fibers in the vessel walls, weakening them and potentially causing them to bulge outward, creating a risk of fatal rupture. Particularly, aneurysms in the aorta, the largest artery in the body, represent the second most common type of aortic disease and are a significant cause of death globally. Patients experiencing symptoms or rapid growth of an aneurysm are encouraged to seek treatment, with minimally invasive approaches recommended for those with comorbidities or at risk from open surgery.

Traditionally, aneurysms are treated non-invasively by inserting a stent graft to reinforce the vessel walls and prevent blood from entering the aneurysm. However, this method can fail due to leaks between the stent graft and the endothelial wall, which can allow blood to re-enter the aneurysm. To address these leaks, known as endoleaks, embolic agents are used, but they can be expensive, challenging to apply, and sometimes ineffective, often requiring further procedures. Now, scientists at the Terasaki Institute for Biomedical Innovation (TIBI, Los Angeles, CA, USA) have created an innovative, injectable shear-thinning hydrogel for the treatment of abdominal aortic aneurysms that not only more effectively seals them off but also halts their growth.

This embolic agent was formulated using a gelatin-based shear-thinning hydrogel that solidifies upon injection, enhanced with silicate nanoplatelets for improved cohesion and blood clotting. Additionally, it incorporates doxycycline (DOX), an FDA-approved drug known for eliminating dysfunctional endothelial cells and neutralizing MMPs. DOX achieves this through both an immediate burst release for rapid cell removal and a sustained release for long-term MMP inhibition. This dual-action process was validated in animal studies using the new hydrogel in pig aorta samples.

Further experiments showed that adding doxycycline improved the hydrogel's injectability, cohesion, and embolic strength, reducing clotting time by 33%. The new hydrogel also succeeded in embolization in a laboratory model of endoleaks and was shown to impact the expression of various proteins critical to endothelial cell function, blood vessel development, and clot formation. These results suggest the potential for using this novel hydrogel to treat aneurysms elsewhere in the body and highlight the need for further studies on its long-term safety and effectiveness.

“The work here represents a significant advancement in the treatment of aneurysms,” said Ali Khademhosseinini, Ph.D., TIBI’s Director and CEO. “It is our hope that this work can be expanded into further tests and clinical trials so that we may bring this technology to the patients.”

Related Links:

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Wireless Mobile ECG Recorder
Harness System

Print article


Surgical Techniques

view channel
Image: The endoscopic device can 3D image the stiffness of individual biological cells and complex organisms (Photo courtesy of University of Nottingham)

World’s First Microscopic Probe to Revolutionize Early Cancer Diagnosis

In the early stages of cancer, the cells are significantly softer than normal cells, which facilitates their movement through small spaces and contributes to the rapid spread of the disease, a process... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.